FdaApplication
ANDA 210871
Identifiers
- fda_app_no: ANDA210871
Properties
| Property | Value |
|---|---|
| applicant_name | LUOXIN AUROVITAS PHARMA CHENGDU CO LTD |
| application_type | ANDA |
| approval_date | 2021-01-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOBRAMYCIN | TOBRAMYCIN | 300MG/5ML | SOLUTION;INHALATION |
1 product